BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Critical Outcome Technologies preclinical data

In a mouse model of ovarian cancer, 40 mg/kg IV COTI-2 daily for 5 days/week produced a significantly greater complete remission (CR) rate vs. vehicle-treated...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >